Regulation of Down syndrome critical region 1 expression by nuclear factor of activated T cells in megakaryocytes

British Journal of Haematology

Volumn 144, Issue 3, 2009, Pages 395-408

  Kyttälä, Satu ^a   Habermann, Ivonne ^a   Minami, Takashi ^b   Ehninger, Gerhard ^a   Kiani, Alexander ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Calcineurin; Collagen; DSCR1; Megakaryocytes; NFAT

Indexed keywords

CALCINEURIN; CALCINEURIN INHIBITOR; CYCLOSPORIN A; FAS LIGAND; FIBRILLAR COLLAGEN; PROTEIN DSCR1; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; GENE CONTROL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MEGAKARYOCYTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

BLOTTING, WESTERN; CALCINEURIN; CALCIUM SIGNALING; CELL LINE; GENE EXPRESSION REGULATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEGAKARYOCYTES; MUSCLE PROTEINS; NFATC TRANSCRIPTION FACTORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 58649097496     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07490.x     Document Type: Article

References (63)

1. Abbasi, S., Lee, J.D., Su, B., Chen, X., Alcon, J.L., Yang, J., Kellems, R.E. Xia, Y. (2006) Protein kinase-mediated regulation of calcineurin through the phosphorylation of modulatory calcineurin-interacting protein 1. The Journal of Biological Chemistry, 281, 7717 7726.
2. Aramburu, J., Yaffe, M.B., López-Rodriguez, C., Cantley, L.C., Hogan, P.G. Rao, A. (1999) Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science, 285, 2129 2133.
3. Aramburu, J., Rao, A. Klee, C.B. (2000) Calcineurin: from structure to function. Current Topics in Cellular Regulation, 36, 237 295.
4. Arron, J.R., Winslow, M.M., Polleri, A., Chang, C.P., Wu, H., Gao, X., Neilson, J.R., Chen, L., Heit, J.J., Kim, S.K., Yamasaki, N., Miyakawa, T., Francke, U., Graef, I.A. Crabtree, G.R. (2006) NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature, 441, 595 600.
5. Avanzi, G.C., Lista, P., Giovinazzo, B., Miniero, R., Saglio, G., Benetton, G., Coda, R., Cattoretti, G. Pegoraro, L. (1988) Selective growth response to IL-3 of a human leukaemic cell line with megakaryoblastic features. British Journal of Haematology, 69, 359 366.
6. Bartley, T.D., Bogenberger, J., Hunt, P., Li, Y.S., Lu, H.S., Martin, F., Chang, M.S., Samal, B., Nichol, J.L., Swift, S., Johnson, J., Hsu, R.-Y., Parker, V.P., Suggs, S., Skrine, J.D., Merewether, L.A., Clogston, C., Hsu, E., Hokom, M.M., Hornkohl, A., Choi, E., Pangelinan, M., Sun, Y., Mar, V., McNinch, J., Simonet, L., Jacobsen, F., Xie, C., Shutter, J., Chute, H., Basu, R., Selander, L., Trollinger, D., Sieu, L., Padilla, D., Trail, G., Elliott, G., Izumi, R., Covey, T., Crouse, J., Garcia, A., Xu, W., Del Castillo, J., Biron, J., Cole, S., Hu, M.C.-T., Pacifici, R., Ponting, I., Saris, C., Wen, D., Yung, Y.P., Lin, H. Rosselman, R.A. (1994) Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell, 77, 1117 1124.
7. Berlanga, O., Bobe, R., Becker, M., Murphy, G., Leduc, M., Bon, C., Barry, F.A., Gibbins, J.M., Garcia, P., Frampton, J. Watson, S.P. (2000) Expression of the collagen receptor glycoprotein VI during megakaryocyte differentiation. Blood, 96, 2740 2745.
8. Bonci, D., Hahne, M., Felli, N., Peschle, C. De Maria, R. (2004) Potential role of APRIL as autocrine growth factor for megakaryocytopoiesis. Blood, 104, 3169 3172.
9. Briddon, S.J., Melford, S.K., Turner, M., Tybulewicz, V. Watson, S.P. (1999) Collagen mediates changes in intracellular calcium in primary mouse megakaryocytes through syk-dependent and -independent pathways. Blood, 93, 3847 3855.
10. Caetano, M.S., Viera-de-Abreu, A., Teixeira, L.K., Werneck, M.B.F., Barcinski, M.A. Viola, J.P.B. (2002) NFATC2 transcription factor regulates cell cycle progression during lymphocyte activation: evidence of its involvement in the control of cyclin gene expression. The FASEB Journal, 16, 1940 1942.
11. Cano, E., Canellada, A., Minami, T., Iglesias, T. Redondo, J.M. (2005) Depolarization of neural cells induces transcription of the Down syndrome critical region 1 isoform 4 via a calcineurin/nuclear factor of activated T cells-dependent pathway. The Journal of Biological Chemistry, 280, 29435 29443.
12. Choi, E.S., Nichol, J.L., Hokom, M.M., Hornkohl, A.C. Hunt, P. (1995) Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional. Blood, 85, 402 413.
13. Crabtree, G.R. Olson, E.N. (2002) NFAT signaling: Choreographing the social lives of cells. Cell, 109, S67 S79.
14. Cripe, L.D. Hromas, R. (1998) Malignant disorders of megakaryocytes. Seminars in Hematology, 35, 200 209.
15. den Dekker, E., Gorter, G., van der Vuurst, H., Heemskerk, J.W. Akkerman, J.W. (2001) Biogenesis of G-protein mediated calcium signaling in human megakaryocytes. Thrombosis and Haemostasis, 86, 1106 1113.
16. Deutsch, V.R. Tomer, A. (2006) Megakaryocyte development and platelet production. British Journal of Haematology, 134, 453 466.
17. 2+ response amplitude and duration. Nature, 386, 855 858.
18. Dolmetsch, R.E., Xu, K. Lewis, R.S. (1998) Calcium oscillations increase the efficiency and specificity of gene expression. Nature, 392, 933 936.
19. Endo, T.A., Masuhara, M., Yokouchi, M., Suzuki, R., Sakamoto, H., Mitsui, K., Matsumoto, A., Tanimura, S., Ohtsubo, M., Misawa, H., Miyazaki, T., Leonor, N., Taniguchi, T., Fujita, T., Kanakura, Y., Komiya, S. Yoshimura, A. (1997) A new protein containing an SH2 domain that inhibits JAK kinases. Nature, 387, 921 924.
20. Fuentes, J.J., Pritchard, M.A., Planas, A.M., Bosch, A., Ferrer, I. Estivill, X. (1995) A new human gene from the Down syndrome critical region encodes a proline-rich protein highly expressed in fetal brain and heart. Human Molecular Genetics, 4, 1935 1944.
21. Fuentes, J.J., Genescà, L., Kingsbury, T.J., Cunningham, K.W., Pérez-Riba, M., Estivill, X. de la Luna, S. (2000) DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways. Human Molecular Genetics, 9, 1681 1690.
22. Ghosh, P., Sica, A., Cippitelli, M., Subleski, J., Lahesmaa, R., Young, H.A. Rice, N.R. (1996) Activation of nuclear factor of activated T cells in a cyclosporin A-resistant pathway. The Journal of Biological Chemistry, 271, 7700 7704.
23. Groet, J., McElwaine, S., Spinelli, M., Rinaldi, A., Burtscher, I., Mulligan, C., Mensah, A., Cavani, S., Dagna-Bricarelli, F., Basso, G., Cotter, F.E. Nizetic, D. (2003) Acquired mutations in GATA1 in neonates with Down's syndrome with transient myeloid disorder. The Lancet, 361, 1617 1620.
24. Hesser, B.A., Liang, X.H., Camenisch, G., Yang, S., Lewin, D.A., Scheller, R., Ferrara, N. Gerber, H.P. (2004) Down syndrome critical region protein 1 (DSCR1), a novel VEGF target gene that regulates expression of inflammatory markers on activated endothelial cells. Blood, 104, 149 158.
25. Hitzler, J.K. Zipursky, A. (2005) Origins of leukemia in children with Down syndrome. Nature Reviews Cancer, 5, 11 20.
26. Hogan, P.G., Chen, L., Nardone, J. Rao, A. (2003) Transcriptional regulation by calcium, calcineurin, and NFAT. Genes and Development, 17, 2205 2232.
27. Houwerzijl, E.J., Blom, N.R., van der Want, J.J., Vellenga, E. de Wolf, J.T. (2006) Megakaryocytic dysfunction in myelodysplastic syndromes and idiopathic thrombocytopenic purpura is in part due to different forms of cell death. Leukemia, 20, 1937 1942.
28. Kacena, M.A., Nelson, T., Clough, M.E., Lee, S.K., Lorenzo, J.A., Gundberg, C.M. Horowitz, M.C. (2006) Megakaryocyte-mediated inhibition of osteoclast development. Bone, 39, 991 999.
29. Kiani, A., Viola, J.P.B., Lichtman, A.H. Rao, A. (1997) Down-regulation of IL-4 gene transcription and control of Th2 cell differentiation by a mechanism involving NFAT1. Immunity, 7, 849 860.
30. Kiani, A., Rao, A. Aramburu, J. (2000) Manipulating immune responses with immunosuppressive agents that target NFAT. Immunity, 12, 359 372.
31. Kiani, A., Garcia-Cozar, F.J., Habermann, I., Laforsch, S., Aebischer, T., Ehninger, G. Rao, A. (2001) Regulation of interferon-γ gene expression by nuclear factor of activated T cells. Blood, 98, 1480 1488.
32. + cells: down-regulation upon myeloid differentiation. Journal of Leukocyte Biology, 76, 1057 1065.
33. + cells: regulation of Fas ligand gene expression in megakaryocytes. Experimental Hematology, 35, 757 770.
34. Luo, C., Burgeon, E., Carew, J.A., McCaffrey, P.G., Badalian, T.M., Lane, W.S., Hogan, P.G. Rao, A. (1996) Recombinant NFAT1 (NFATp) is regulated by calcineurin in T cells and mediates transcription of several cytokine genes. Molecular and Cellular Biology, 16, 3955 3966.
35. Macian, F. (2005) NFAT proteins: key regulators of T-cell development and function. Nature Reviews Immunology, 5, 472 484.
36. Majka, M., Baj-Krzyworzeka, M., Kijowski, J., Reca, R., Ratajczak, J. Ratajczak, M.Z. (2001) In vitro expansion of human megakaryocytes as a tool for studying megakaryocytic development and function. Platelets, 12, 325 332.
37. Massey, G.V., Zipursky, A., Chang, M.N., Doyle, J.J., Nasim, S., Taub, J.W., Ravindranath, Y., Dahl, G. Weinstein, H.J. Children′s Oncology Group (COG) (2006) A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481. Blood, 107, 4606 4613.
38. Matsuda, S., Miwa, Y., Hirata, Y., Minowa, A., Tanaka, J., Nishida, E. Koyasu, S. (2004) Negative feedback loop in T-cell activation through MAPK-catalyzed threonine phosphorylation of LAT. The EMBO Journal, 23, 2577 2585.
39. + cells are correlated with different levels of platelet release. Blood, 99, 888 897.
40. Minami, T., Horiuchi, K., Miura, M., Abid, M.R., Takabe, W., Noguchi, N., Kohro, T., Ge, X., Aburatani, H., Hamakubo, T., Kodama, T. Aird, W.C. (2004) Vascular endothelial growth factor- and thrombin-induced termination factor, Down syndrome critical region-1, attenuates endothelial cell proliferation and angiogenesis. The Journal of Biological Chemistry, 279, 50537 50554.
41. Minami, T., Miura, M., Aird, W.C. Kodama, T. (2006) Thrombin-induced autoinhibitory factor, Down syndrome critical region-1, attenuates NFAT-dependent vascular cell adhesion molecule-1 expression and inflammation in the endothelium. The Journal of Biological Chemistry, 281, 20503 20520.
42. Monticelli, S., Solymar, D.C. Rao, A. (2004) Role of NFAT proteins in IL13 gene transcription in mast cells. The Journal of Biological Chemistry, 279, 36210 36218.
43. 2+)i elevation and increased tyrosine phosphorylation in human megakaryocytes. Thrombosis and Haemostasis, 82, 1153 1159.
44. Murphy, L.L. Hughes, C.C. (2002) Endothelial cells stimulate T cell NFAT nuclear translocation in the presence of cyclosporin A: involvement of the wnt/glycogen synthase kinase-3 beta pathway. The Journal of Immunology, 169, 3717 3725.
45. Naka, T., Narazaki, M., Hirata, M., Matsumoto, T., Minamoto, S., Aono, A., Nishimoto, N., Kajita, T., Taga, T., Yoshizaki, K., Akira, S. Kishimoto, T. (1997) Structure and function of a new STAT-induced STAT-inhibitor. Nature, 387, 924 929.
46. Patel, S.R., Hartwig, J.H. Italiani, J.R.J. (2005) The biogenesis of platelets from megakaryocyte proplatelets. The Journal of Clinical Investigation, 115, 3348 3354.
47. Plyte, S., Boncristiano, M., Fattori, E., Galvagni, F., Paccani, S.R., Majolini, M.B., Oliviero, S., Ciliberto, G., Telford, J.L. Baldari, C.T. (2001) Identification and characterization of a novel nuclear factor of activated T-cells-1 isoform expressed in mouse brain. The Journal of Biological Chemistry, 276, 14350 14358.
48. Rothermel, B., Vega, R.B., Yang, J., Wu, H., Bassel-Duby, R. Williams, R.S. (2000) A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling. The Journal of Biological Chemistry, 275, 8719 8725.
49. Ryeom, S., Greenwald, R.J., Sharpe, A.H. McKeon, F. (2003) The threshold pattern of calcineurin-dependent gene expression is altered by loss of the endogenous inhibitor calcipressin. Nature Immunology, 4, 874 881.
50. Sato, T., Fuse, A., Eguchi, M., Hayashi, Y., Ryo, R., Adachi, M., Kishimoto, Y., Teramura, M., Mizoguchi, H., Shima, Y., Komori, I., Sunami, S., Okimoto, Y. Nakajima, H. (1989) Establishment of a human leukaemic cell line (CMK) with megakaryocytic characteristics from a Down's syndrome patient with acute megakaryoblastic leukaemia. British Journal of Haematology, 72, 184 190.
51. Sato, T., Ono, M., Fujita, H., Tanaka, N., Tomiyama, J., Sakamoto, Y., Takano, Y., Murota, S.I. Morita, I. (2003) Development of a liquid culture system for megakaryocyte terminal differentiation: fibrinogen promotes megakaryocytopoiesis but not thrombopoiesis. British Journal of Haematology, 121, 315 323.
52. Schulze, H. Shivdasani, R.A. (2004) Molecular mechanisms of megakaryocyte differentiation. Seminars in Thrombosis and Hemostasis, 30, 389 398.
53. Shaw, K.T., Ho, A.M., Raghavan, A., Kim, J., Jain, J., Park, J., Sharma, S., Rao, A. Hogan, P.G. (1995) Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells. Proceedings of the National Academy of Sciences of the United states of America, 92, 11205 11209.
54. Starr, R., Willson, T.A., Viney, E.M., Murray, L.J.L., Rayner, J.R., Jenkins, B.J., Gonda, T.J., Alexander, W.S., Metcalf, D., Nicola, N.A. Hilton, D.J. (1997) A family of cytokine-inducible inhibitors of signalling. Nature, 387, 917 921.
55. Tefferi, A. (2005) Pathogenesis of myelofibrosis with myeloid metaplasia. Journal of Clinical Oncology, 23, 8520 8530.
56. + cord blood-derived dendritic cells. Gene Therapy, 9, 1551 1560.
57. 2+ oscillation. The EMBO Journal, 22, 3825 3832.
58. Tortolani, P.J., Johnston, J.A., Bacon, C.M., McVicar, D.W., Shimosaka, A., Linnekin, D., Longo, D.L. O'Shea, J.J. (1995) Thrombopoietin induces tyrosine phosphorylation and activation of the Janus kinase, JAK2. Blood, 85, 3444 3451.
59. + progenitor cells to study transgenes in the platelet environment. Circulation Research, 95, e36 e44.
60. Wechsler, J., Greene, M., McDevitt, M.A., Anastasi, J., Karp, J.E., Le Beau, M.M. Crispino, J.D. (2002) Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nature Genetics, 32, 148 152.
61. Yang, J., Rothermel, B., Vega, R.B., Frey, N., McKinsey, T.A., Olson, E.N., Bassel-Duby, R. Williams, R.S. (2000) Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles. Circulation Research, 87, E61 E68.
62. Zipursky, A. (2003) Transient leukaemia - a benign form of leukaemia in newborn infants with trisomy 21. British Journal of Haematology, 120, 930 938.
63. Zipursky, A., Poon, A. Doyle, J. (1992) Leukemia in Down syndrome: a review. Pediatric Hematology and Oncology, 9, 139 149.